Trial · NCT03772587
Results by group206
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 206
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) as a Measure of Safety and Tolerability | Placebo | 11 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) as a Measure of Safety and Tolerability | Nipocalimab 5 Milligrams/Kilogram (mg/kg) | 12 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) as a Measure of Safety and Tolerability | Nipocalimab 30 mg/kg | 9 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) as a Measure of Safety and Tolerability | Nipocalimab 60 mg/kg | 12 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) as a Measure of Safety and Tolerability | Nipocalimab 60 mg/kg (Q2W) | 12 | Participants | ||
| Number of Participants With Treatment-emergent Serious Adverse Events (SAEs) | Placebo | 2 | Participants | ||
| Number of Participants With Treatment-emergent Serious Adverse Events (SAEs) | Nipocalimab 5 mg/kg | 0 | Participants | ||
| Number of Participants With Treatment-emergent Serious Adverse Events (SAEs) | Nipocalimab 30 mg/kg | 1 | Participants | ||
| Number of Participants With Treatment-emergent Serious Adverse Events (SAEs) | Nipocalimab 60 mg/kg | 0 | Participants | ||
| Number of Participants With Treatment-emergent Serious Adverse Events (SAEs) | Nipocalimab 60 mg/kg (Q2W) | 0 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESI) | Placebo | 0 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESI) | Nipocalimab 5 mg/kg | 0 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESI) | Nipocalimab 30 mg/kg | 0 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESI) | Nipocalimab 60 mg/kg | 0 | Participants | ||
| Number of Participants With Treatment-emergent Adverse Events of Special Interest (AESI) | Nipocalimab 60 mg/kg (Q2W) | 0 | Participants | ||
| Change From Baseline to Day 57 in the Myasthenia Gravis - Activities of Daily Living (MG-ADL) Total Score | Placebo | -1.8 | Standard Deviation 3.22 | score on a scale | |
| Change From Baseline to Day 57 in the Myasthenia Gravis - Activities of Daily Living (MG-ADL) Total Score | Nipocalimab 5 mg/kg | -2.5 | Standard Deviation 2.41 | score on a scale | |
| Change From Baseline to Day 57 in the Myasthenia Gravis - Activities of Daily Living (MG-ADL) Total Score | Nipocalimab 30 mg/kg | -3.9 | Standard Deviation 3.00 | score on a scale | |
| Change From Baseline to Day 57 in the Myasthenia Gravis - Activities of Daily Living (MG-ADL) Total Score | Nipocalimab 60 mg/kg | -1.5 | Standard Deviation 2.82 | score on a scale | |
| Change From Baseline to Day 57 in the Myasthenia Gravis - Activities of Daily Living (MG-ADL) Total Score | Nipocalimab 60 mg/kg (Q2W) | -3.9 | Standard Deviation 3.66 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03772587/results